Triflupromazine

Triflupromazine

Triflupromazine is a typical antipsychotic medication belonging to the phenothiazine class. It is primarily used in the treatment of schizophrenia and other psychotic disorders. Triflupromazine is known for its sedative properties and is sometimes used to manage severe nausea and vomiting.

Chemical Structure

Triflupromazine is a derivative of phenothiazine, characterized by the presence of a trifluoromethyl group. Its chemical formula is C₁₈H₁₉F₃N₂S, and it has a molecular weight of 352.42 g/mol. The structure of triflupromazine can be visualized in the following images:

Chemical structure of Triflupromazine

3D model of Triflupromazine

Pharmacology

Triflupromazine works by blocking dopamine receptors in the brain, which helps to reduce symptoms of psychosis. It also has antihistaminic and anticholinergic properties, contributing to its sedative effects. The medication is metabolized in the liver and excreted primarily in the urine.

Medical Uses

Triflupromazine is used to treat a variety of psychiatric conditions, including:

• Schizophrenia
• Severe anxiety
• Mania

It is also used as an antiemetic to control severe nausea and vomiting, particularly in patients undergoing chemotherapy.

Side Effects

Common side effects of triflupromazine include:

• Drowsiness
• Dry mouth
• Constipation
• Blurred vision

Serious side effects may include:

• Tardive dyskinesia
• Neuroleptic malignant syndrome
• Agranulocytosis

History

Triflupromazine was first introduced in the 1950s as one of the early antipsychotic medications. It was developed as part of the phenothiazine class, which includes other well-known antipsychotics such as chlorpromazine.

Related Pages

• Antipsychotic
• Phenothiazine
• Schizophrenia
• Dopamine receptor antagonist